Michael Sha

Dr. Sha is a highly recognized R&D leader with more than 20 years of experience in molecular diagnostics. His R&D at previous companies has provided extensive opportunities to work with NGS and its application in liquid biopsy for cancer diagnostic, fetal cell diagnostics for NIPT, metagenomics, in vitro diagnostics/ companion diagnostic, and bio-nanotechnology. Dr. Sha worked as the R&D director to lead and develop functional screening of uncultivable bacteria through microfluidic chip PCR and NGS at GALT Inc. His focus, work ethic, and drive have led multiple teams to receive numerous awards, over $3 million for CTC/ctDNA NGS and cardiac biomarkers POC projects for the Intensity Innovation Program through three years continually during working at Thermo Fisher Inc. He also worked as a senior staff scientist to lead the molecular biology team for developing Chip PCR for NGS and CMOS-based Sequencing System at Illumina Inc. At Roche Diagnostics, Dr. Sha focused to discover biomarkers for the rare fetal cell from the maternal blood circulation for noninvasive prenatal diagnosis. Dr. Sha was a postdoctoral in HPV E6-mediated p53 protein degradation research at the school of medicine, UCSF. He holds ten patents and has published over fifty papers.